imipramine has been researched along with Cancer of Pituitary in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henneberry, RC | 1 |
| Jahangeer, S | 1 |
| Lysko, PG | 1 |
| Turkington, RW | 1 |
2 other studies available for imipramine and Cancer of Pituitary
| Article | Year |
|---|---|
Transport of beta-adrenergic antagonists in the absence of beta-adrenergic receptors in rat pituitary tumor cells.
Topics: Adrenergic beta-Antagonists; Animals; Binding, Competitive; Biological Transport; Cell Line; Colfors | 1986 |
Serum prolactin levels in patients with gynecomastia.
Topics: Adolescent; Adult; Amenorrhea; Animals; Caseins; Cell Line; Chlorpromazine; Choriocarcinoma; Gynecom | 1972 |